Back
United Therapeutics 10K Form
Buy
55
UTHR
United Therapeutics
Last Price:
264.33
Seasonality Move:
10.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-01 | 10Q | UTHR/United Therapeutics Quarterly |
| 2023-08-02 | 10Q | UTHR/United Therapeutics Quarterly |
| 2023-05-03 | 10Q | UTHR/United Therapeutics Quarterly |
| 2022-11-02 | 10Q | UTHR/United Therapeutics Quarterly |
| 2022-08-03 | 10Q | UTHR/United Therapeutics Quarterly |
| 2022-05-04 | 10Q | UTHR/United Therapeutics Quarterly |
Receive UTHR News And Ratings
See the #1 stock for the next 7 days that we like better than UTHR
UTHR Financial Statistics
Sales & Book Value
| Annual Sales: | $2.33B |
|---|---|
| Cash Flow: | $338.3M |
| Price / Cash Flow: | 17.47 |
| Annual Sales: | $120.76 |
| Price / Book: | 2.2 |
Profitability
| EPS (TTM): | 21.15000 |
|---|---|
| Net Income (TTM): | $1.05B |
| Gross Margin: | $2.07B |
| Return on Equity: | 19.05% |
| Return on Assets: | 15.58% |
United Therapeutics Earnings Forecast
Key United Therapeutics Financial Ratios
- The Gross Profit Margin over the past 25 years for UTHR is 88.94%.
- The Selling, General & Administrative Expenses for UTHR have been equal to 20.50% of Gross Profit Margin.
- The Research & Development expenses have been 17.53% of Revenue.
- The Interest Expense is 6.02% of Operating Income.
- The Net Earning history of UTHR is 42.31% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 17 years.
United Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | UTHR |
| CUSIP: | 91307C |
| Website: | unither.com |
Debt
| Debt-to-Equity Ratio: | 0.11 |
|---|---|
| Current Ratio: | 3.77 |
| Quick Ratio: | 3.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 13.34 |
|---|---|
| Forward P/E Ratio: | 9.87 |
UTHR Technical Analysis vs Fundamental Analysis
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Buy
The current United Therapeutics [UTHR] share price is $264.27. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.